News for Healthier Living

Polyendocrine Metabolic Syndrome Doesn't End at Menopause and Neither Should Its Care

Polyendocrine Metabolic Syndrome (PMOS), formerly PCOS, is the most common hormonal and metabolic disorder in women of reproductive age, affecting up to 13% and contributing to nearly 40% of infertility cases. FAU researchers reviewed more than 2,200 studies and identified 29 focusing on non-pharmacological care in midlife and reproductive aging.

May 18, 2026


May 19 2026

May 18 2026

May 17 2026

May 16 2026

May 15 2026

May 14 2026

May 13 2026

May 12 2026

May 11 2026

May 10 2026

May 8 2026

May 7 2026

May 6 2026

May 5 2026